VC
DERM

Vivo Capital’s Dermira, Inc. DERM Stock Holding History

Vivo Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-700,000
Closed -$6.69M – 46
2019
Q2 		$6.69M Hold
700,000
– – 0.63% 32
2019
Q1 		$9.48M Buy
+700,000
New +$5.84M 0.95% 28

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vivo Capital's DERM Position: Q3 2019 in Review

Vivo Capital sold out of Dermira, Inc. (DERM) in Q3 2019, closing a stake of 700,000 shares — an estimated $6.69M sold.

Vivo Capital first reported a position in DERM in Q1 2019 and held it in 2 quarters. The position peaked at $9.48M in Q1 2019. 131 funds tracked by Wall St. Rank hold DERM as of Q3 2019.

  • Vivo Capital reported no remaining Dermira, Inc. position as of Q3 2019 after selling out during the quarter.
  • Vivo Capital sold 700,000 Dermira, Inc. shares in Q3 2019, an estimated $6.69M.
  • Vivo Capital first reported a position in Dermira, Inc. in Q1 2019 and held it in 2 quarters.
  • Vivo Capital's Dermira, Inc. position peaked at $9.48M in Q1 2019.
  • 131 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2019.

Based on Vivo Capital's 13F filing for Q3 2019, filed 13 Nov 2019.